InfuSystem Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by InfuSystem Holdings, Inc. on April 7, 2011, covering events occurring on April 1, 2011. The company is incorporated in Delaware and operates with principal executive offices in Madison Heights, Michigan.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, or total debt levels. The report focuses exclusively on a modification to the company's existing credit facility rather than presenting periodic financial performance data.
Material Changes
- Credit Agreement Amendment: On April 1, 2011, InfuSystem Holdings, Inc., InfuSystem, Inc., and First Biomedical, Inc. (the "Borrowers") entered into a Second Amendment to their Credit Agreement dated June 15, 2010.
- Covenant Modification: The amendment modified covenants restricting capital expenditures and capital leases entered into by the Borrowers and their subsidiaries.
- Guarantor Addition: Concurrently with the amendment, IFC LLC, a wholly-owned subsidiary of Holdings, became a subsidiary guarantor under the Credit Agreement.
- Lenders: The agreement involves Bank of America, N.A. (Administrative Agent and Lender) and Keybank National Association (Lender).
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risk factors beyond the structural changes to the debt agreement. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the specific terms of the modified capital expenditure and capital lease covenants in the Second Amendment to the Credit Agreement (Exhibit 10.1).
- Confirm the financial impact of IFC LLC becoming a subsidiary guarantor on the company's consolidated balance sheet.
- Review the original June 15, 2010 Credit Agreement to understand the baseline restrictions that were amended.